Cyclerion Therapeutics Inc. Revenue 2019–2025
Cyclerion Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cyclerion Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Cyclerion Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 1.0 M, a 440.72% increase year-over-year.
- Cyclerion Therapeutics Inc. annual revenue for 2025 was 2.1 M, a 3.70% increase from 2024.
- Cyclerion Therapeutics Inc. annual revenue for 2024 was 2.0 M.
- Cyclerion Therapeutics Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Cyclerion Therapeutics Inc. annual revenue for 2022 was 297000.
Cyclerion Therapeutics Inc. (CYCN) — Frequently Asked Questions
Cyclerion Therapeutics Inc. (CYCN) is a publicly traded US company. It has a market capitalization of $10M. In fiscal 2025 it reported revenue of $2M and net income of -$4M. Explore CYCN's stock price, financial statements, earnings history, margins and key ratios below.
What is Cyclerion Therapeutics Inc.'s market cap?
Cyclerion Therapeutics Inc. (CYCN) has a market capitalization of $10M.
What is the CYCN stock price?
CYCN trades at $3.04 (-1.62% on the day).
How much revenue does Cyclerion Therapeutics Inc. make?
Cyclerion Therapeutics Inc. reported revenue of $2M in fiscal 2025.
Is CYCN profitable?
In fiscal 2025, Cyclerion Therapeutics Inc. reported net income of -$4M.